Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Fibrosis

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

239 public trials 57 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Completed

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

NCT00639496

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: U.Z. Ghent Ghent, Belgium

Hôpital A. Calmette Lille, France

Klinikum Grosshadern Munich, Germany

U.O. di Pneumologia-Ospedale Arezzo, Italy

View Trial Details

Completed

Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis

NCT00514683

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: 1199.30.54002 Boehringer Ingelheim Investigational Site Mendoza, Argentina

1199.30.61005 Boehringer Ingelheim Investigational Site South Brisbane, Queensland, Australia

1199.30.61003 Boehringer Ingelheim Investigational Site Toorak Gardens, South Australia, Australia

1199.30.61004 Boehringer Ingelheim Investigational Site Woodville, South Australia, Australia

View all 92 locations

View Trial Details

Completed

Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases

NCT01825538

Conditions: Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +9 more
Locations: The Ohio State University Wexner Medical Center Columbus, Ohio, United States

View Trial Details

Completed

The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis

NCT00504621

Conditions: Fatigue, Fibrosis, Hemic and Lymphatic Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Diffuse Fibrotic Lung Disease

NCT00000596

Conditions: Fibrosis, Hemic and Lymphatic Diseases, Hypersensitivity, +11 more
Locations: Not specified

View Trial Details

Completed

The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease

NCT01055730

Conditions: Behavior, Dyspnea, Fibrosis, +13 more
Locations: John Muir Health Concord, California, United States

Seton Pulmonary & Cardiac Rehabilitation Daly City, California, United States

Yale University School of Medicine New Haven, Connecticut, United States

Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Dyspnea in Patients With Pulmonary Fibrosis

NCT00611182

Conditions: Dyspnea, Fibrosis, Lung Diseases, +8 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

Oral Paricalcitol in Kidney Transplant Recipients

NCT00587158

Conditions: Chronic Disease, Disease Attributes, Endocrine System Diseases, +21 more
Locations: Mayo Clinic Scottsdale, Arizona, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung Disease

NCT01653730

Conditions: Chronic Disease, Chronic Obstructive Lung Disease, Disease Attributes, +9 more
Locations: The Ottawa Hospital Rehabilitation Centre Ottawa, Ontario, Canada

View Trial Details

Completed

Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis

NCT01442779

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: Texas Tech University Health Sciences Center Lubbock, Texas, United States

View Trial Details